MedPath

A multicenter randomized controlled clinical trial for 'Sanhuangfu Kang Oil' on acute radiation-induced skin lesions in patients with breast cancer

Phase 1
Conditions
Breast cancer
Registration Number
ITMCTR1900002612
Lead Sponsor
The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

(1) Meet the diagnostic criteria for acute radiation dermatitis.
(2) Radiation therapy for the first time after breast cancer surgery.
(3) KPS score >= 60 points.
(4) Aged 18-75 years.
(5) Life expectancy is at least 6 months.
(6) Signing written informed consent

Exclusion Criteria

(1) Pregnant, lactating women, who have a pregnancy plan.
(2) Combine other skin conditions, such as connective tissue diseases.
(3) Wounded infected person.
(4) Diabetic patients with poor drug control.
(5) Mental and behavioral disorders are not adequately informed.
(6) Suspected or indeed have a history of alcohol, drug abuse, and can not be combined with treatment.
(7) Those who have cognitive impairment or low level of education cannot understand and correctly fill out various scales

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Evaluation of skin lesion classification of acute radiation dermatitis;Acute radiation dermatitis pain, erythema, itching relief time;
Secondary Outcome Measures
NameTimeMethod
Quality of life indicator;
© Copyright 2025. All Rights Reserved by MedPath